AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine. “Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed and will be informed by emerging data,” a spokesperson for the company said in a statement. The Financial Times first reported the news, citing Sandy Douglas, a research group leader at Oxford. Vaccine makers Pfizer/BioNTech and Moderna also previously said they were working on Omicron- specific COVID-19 vaccines. I agree to the Terms of Use and acknowledge that I have read the Privacy PolicyRead Next

Source: Philippine Daily Inquirer December 22, 2021 09:37 UTC